In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...

New research shows calves fed waste milk develop different immune cell and cytokine profiles than those fed salable milk, ...

Researchers found that in mouse models (in a lab), SARS‑CoV‑2 mRNA vaccination triggered strong type I interferon signals, ...

Cancer immunotherapy has been transformed by engineered T cells, but those bespoke treatments are slow, expensive, and out of ...

Dr. Gil Mor discusses sex-specific placental responses and long-term immune alterations from prenatal virus exposure.

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

2025, A Year of Momentum: Advancing Toward a Potential Breakthrough in Ovarian Cancer Treatment ...

Stanford researchers have identified a biological pathway that helps explain why mRNA COVID-19 vaccines can, in very rare ...

Cancer researchers have chased the idea of a universal cancer vaccine for decades. The promise sounds bold and almost ...

RNA is usually portrayed as a molecule that works deep inside the cell, helping to turn genetic information into proteins. But new research led by Utrecht University scientist Jack Li shows that RNA ...